SMTL ID : 2xk9.1

Structural analysis of checkpoint kinase 2 (Chk2) in complex with inhibitor PV1533

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

homo-dimer

Ligands

2 x XK9: N-{4-[(1E)-N-(N-hydroxycarbamimidoyl)ethanehydrazonoyl]phenyl}-7-nitro-1H-indole-2-carboxamide(Non-covalent)

XK9.1: 14 residues within 4Å: Chain A: L.17, V.25, K.40, I.42, E.64, L.92, L.94, M.95, E.96, G.98, L.145, T.158, D.159, G.161 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.17, A:K.40, A:K.40, A:L.92 Hydrogen bonds: A:G.161 Salt bridges: A:E.64, A:D.159 XK9.2: 14 residues within 4Å: Chain B: L.17, V.25, K.40, I.42, E.64, L.92, L.94, M.95, E.96, G.98, L.145, T.158, D.159, G.161 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:L.17, B:K.40, B:K.40, B:L.92 Hydrogen bonds: B:D.159, B:G.161 Salt bridges: B:E.64, B:D.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lountos, G.T. et al., Structural Characterization of Inhibitor Complexes with Checkpoint Kinase 2 (Chk2), a Drug Target for Cancer Therapy. J.Struct.Biol. (2011)

Release Date

2011-07-20

Peptides

CHECKPOINT KINASE 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

CHECKPOINT KINASE 2